LONDON & LOS ANGELES–(BUSINESS WIRE)–Crescent Capital Group LP, a leading alternative credit investment firm,
announced today that its European Specialty Lending strategy has
provided financing to support the acquisition of AIO II by funds managed
by Bencis Capital Partners and management. Crescent is also providing
financing to support AIO II’s ongoing buy and build efforts. Terms of
the transaction were not disclosed.

AIO II operates a chain of over 50 pharmacies across the Netherlands
(Medsen) plus a modern large-scale compounding pharmacy (Ceban).

“By providing this critical financing for the acquisition of AIO II,
which operates in a fragmented landscape, the company can continue to
execute on its buy and build growth trajectory,” said Christine Vanden
Beukel, Managing Director and head of Crescent’s European Specialty
Lending strategy. “We are proud to have been able to provide this
two-part financing, which is demonstrative of the types of flexible
capital we provide to companies and sponsors.”

About Crescent Capital Group

Crescent Capital Group LP is headquartered in Los Angeles with offices
in Boston, London and New York. With over 80 investment professionals
and more than 160 employees, the firm invests at all levels of the
capital structure, with a significant focus on below investment grade
credit through strategies that invest in senior bank loans, high yield
debt, mezzanine debt, distressed debt and other private debt securities.
As of December 31, 2018, Crescent Capital Group LP managed more than $24
billion in assets, with a relatively equal split between marketable
securities and privately originated debt investments.

About AIO II

Established in 1998 as a partnership between pharmacies, AIO II is the
holding company of The Netherlands-based pharmacy chain Medsen and
compounding pharmacy Ceban. Medsen is a chain of more than 50 pharmacies
across the Netherlands operating through a simplified ordering and
collection process including 24-hour vending machines and a pharmacy
smart phone application. Ceban is a large-scale compounder of ad-hoc and
in-stock prescriptions supplying to pharmacies, hospitals and dispensing
general practitioners.

About Bencis

Bencis is an independent investment company that supports business
owners and management teams in achieving their growth ambitions. Working
out of offices in Amsterdam and Brussels, and more recently in
Düsseldorf, Bencis has been investing in strong and successful
businesses headquartered in the Netherlands, Belgium and Germany since
1999.

Contacts

Crescent Capital Group
Mendel Communications
Bill Mendel,
+1-212-397-1030
bill@mendelcommunications.com